Evotec to Receive $26 Million in Expanded Bristol Myers Squibb Collaboration
December 16 2022 - 7:57AM
Dow Jones News
By Christian Moess Laursen
Evotec SE said Friday that it will receive a payment of $26
million from Bristol Myers Squibb Co. as part of an expansion of
the two companies' neuroscience collaboration.
The collaboration's portfolio is being expanded by two new drug
discovery projects and a target-based program for further
development, the German biotechnology company said.
Evotec's collaboration with U.S. pharmaceutical company Bristol
Myers Squibb, initiated in 2016, focuses on identifying treatments
for a broad range of brain diseases, Evotec said.
Write to Christian Moess Laursen at christian.moess@wsj.com
(END) Dow Jones Newswires
December 16, 2022 07:42 ET (12:42 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Sep 2023 to Sep 2024
